Gene Bridges licenses Red/ET Recombineering to Novozymes
Dr. Alan Berry, Director, Microbial Physiology and HTS at Novozymes Inc. in Davis, CA said: "The Red/ET system is a very powerful technology, and we look forward to using it to accelerate our strain development efforts."
Red/ET is a method for DNA engineering. Recombineering with Red/ET allows unlimited cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome, according to the company.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.